Vijaya Diagnostic acquires Arya Wellness ops for ₹46.20 crore
- Vijaya Diagnostic Centre acquires Arya Wellness Centre's Assam diagnostic ops for ₹46.20 crore
- Target turnover was ₹26.95 crore in FY25-26, up from ₹25.61 crore in FY24-25
- Deal structured as a slump sale from NEMRIL HRPL JV, not a related-party transaction
- Completion expected within 90 days subject to regulatory approvals

*this image is generated using AI for illustrative purposes only.
Vijaya Diagnostic Centre board approved the acquisition of Arya Wellness Centre's diagnostic operations in Assam for ₹46.20 crore through a slump sale on September 11, 2026.
Acquisition details
The transaction involves the purchase of Arya Wellness Centre's diagnostic business in Assam as a going concern through a slump sale structure from NEMRIL HRPL JV (North Eastern Medical Research Institute Limited – Hexagon Research Private Limited JV). The deal is subject to customary closing working capital adjustments and requisite statutory approvals.
| Parameter | Details |
|---|---|
| Target | Arya Wellness Centre's diagnostic operations |
| Seller | NEMRIL HRPL JV |
| Location | Assam (Guwahati) |
| Deal value | ₹46.20 crore |
| Transaction structure | Slump sale |
| Approving authority | Board of Directors |
| Approval date | September 11, 2026 |
A slump sale involves the transfer of a business undertaking as a whole, including all its assets and liabilities, for a lump sum consideration without assigning individual values to each component. This structure is commonly used in corporate acquisitions of operational business units.
Target financials
The target entity operates within the Healthcare and Diagnostics industry, providing comprehensive pathology and radiology services on a B2C basis. The following table outlines the historical turnover of the acquired business:
| Fiscal Year | Turnover |
|---|---|
| FY25-26 | ₹26.95 crore |
| FY24-25 | ₹25.61 crore |
| FY23-24 | ₹22.99 crore |
The proposed transaction does not constitute a related party transaction. The promoter, promoter group, and group companies of Vijaya Diagnostic Centre do not hold any interest in the seller entity.
Strategic context
The acquisition extends Vijaya Diagnostic Centre's presence into Assam, adding an established diagnostic network in the northeastern region to its portfolio. The deal was sanctioned at the board level, underscoring the company's commitment to geographic expansion through inorganic growth. The transaction is tentatively expected to be completed within 90 days, or such extended period as may be mutually agreed upon by the parties, subject to the fulfilment of customary conditions precedent specified in the Business Transfer Agreement.
Historical Stock Returns for Vijaya Diagnostic Centre
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.21% | -0.23% | +7.86% | +58.92% | +42.84% | 0.0% |
How will the integration of Arya Wellness Centre's operations impact Vijaya Diagnostic Centre's EBITDA margins given the current revenue multiple of approximately 1.7x?
What specific synergies or cost-saving measures does management expect to realize from consolidating the Assam diagnostic network within 90 days?
Does this acquisition signal a broader strategic shift for Vijaya Diagnostic Centre to aggressively expand into other northeastern states beyond Assam?


































